🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gregory J. Riggins

Johns Hopkins University

ORCID: 0000-0002-4538-0436

Also affiliated with Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Information from A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

Figshare(2023)10.1158/0008-5472.22366754.v1
Top 100%
0DataRank
Top 100%0 citations

Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire E. Stevens, Jon W. Teague +50 more

Papers

Driven by 12 papers — median percentile 0. Top paper: “Mutations of the BRAF gene in human cancer”.

Mutations of the BRAF gene in human cancer

Nature(2002)10.1038/nature00766
N/A
1.4DataRank · unranked
10637 citations

Graham R. Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg +56 more

The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa149
N/A
0DataRank · unranked
56 citations

Marina da Costa Rosa, Vittorio Stumpo, Rana Rais, Barbara S. Slusher, Gregory J. Riggins +1 more

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa154
N/A
0DataRank · unranked
44 citations

Matthias Holdhoff, Henry Brem, Avadhut D. Joshi, Christine L. Hann, Ren-Yuan Bai +12 more

Evaluation of a DNA demethylating agent in combination with all-trans retinoic acid for IDH1-mutant gliomas

Neuro-Oncology(2021)10.1093/neuonc/noab263
N/A
0DataRank · unranked
15 citations

Alex Shimura Yamashita, Gregory J. Riggins, Marina da Costa Rosa

Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients

Neuro-Oncology(2021)10.1093/neuonc/noab161
N/A
0DataRank · unranked
8 citations

Shan Huang, Rachel C. Botham, Matthew R. Berry, Stephen Joslyn, Gregory B. Daniel +10 more

Data from A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

(2023)10.1158/0008-5472.c.6495272.v1
N/A
0DataRank · unranked
0 citations

Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire E. Stevens, Jon W. Teague +50 more

Supplementary Information from A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

Figshare(2023)10.1158/0008-5472.22366754.v1
Top 100%
0DataRank
Top 100%0 citations

Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire E. Stevens, Jon W. Teague +50 more

Supplementary Information from A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

(2023)10.1158/0008-5472.22366754
Top 100%
0DataRank
Top 100%0 citations

Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire E. Stevens, Jon W. Teague +50 more

Data from A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy

(2023)10.1158/0008-5472.c.6495272
N/A
0DataRank · unranked
0 citations

Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire E. Stevens, Jon W. Teague +50 more

Data from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers

(2023)10.1158/2326-6066.c.6548869.v1
N/A
0DataRank · unranked
0 citations

Otávia L. Caballero, W.K. Alfred Yung, John N. Weinstein, Gregory J. Riggins, Robert L. Strausberg +2 more

Supplementary Table 6 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers

(2023)10.1158/2326-6066.22538728
Top 100%
0DataRank
Top 100%0 citations

Otávia L. Caballero, W.K. Alfred Yung, John N. Weinstein, Gregory J. Riggins, Robert L. Strausberg +2 more

Repurposing the anthelmintic drug mebendazole in combination with radiation therapy in an isocitrate dehydrogenase mutant glioma model

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf066
N/A
0DataRank · unranked
3 citations

Marina da Costa Rosa, Gregory J. Riggins, Alex Shimura Yamashita